Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.

Authors

Saul Genuth
Wanjie Sun, George Washington UniversityFollow
Patricia ClearyFollow
Xiaoyu Gao
David R. Sell
John LachinFollow
Vincent M. Monnier

Document Type

Journal Article

Publication Date

1-1-2015

Journal

Diabetes

Volume

Volume 64, Issue 1

Issue

1

Inclusive Pages

266-78

Keywords

Diabetes Mellitus, Type 1--Metabolism; Diabetic Angiopathies--Metabolism; Glycosylation End Products, Advanced--Metabolism; Imidazoles--Metabolism; Pyruvaldehyde--Metabolism; Skin--Metabolism

APA Citation

Genuth, S., Sun, W., Cleary, P., Gao, X., Sell, D.R., Lachin, J.; DCCT/EDIC Research Group, Monnier, V.M. (2015) Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 64(1): 266-78

Peer Reviewed

1